Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

40.78 

-0.88 -2.1%

as of Feb 25 '21

52 Week Range:

40.01 62.25


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Dec '15 Oct '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 11.85
16.48
18.94
23.63
63.96
65.54
60.47
42.91
41.65
42.31
growth rate 39.1% 14.9% 24.8% 170.7% 2.5% -4.0% -29.0% -2.9% 1.6%
Earnings BIT 308.19
450.55
511.99
607.70
272.60
729.80
735.30
661.90
692.50
483.90
444.20
growth rate 46.2% 13.6% 18.7% -55.1% 167.7% 0.8% -10.0% 4.6% -30.1% -8.2%
Avg.PE 24.51
24.15
28.25
25.84
82.64
127.68
908.44
-4.04
43.03
43.03
growth rate -1.5% 17.0% -8.5% 219.8% 24.3% 611.5% -100.0% 100.0% 0.0%
ROA 7.91
10.80
11.14
9.43
2.14
0.76
-24.13
0.94
1.16
1.31
growth rate 36.5% 3.2% -15.4% -77.3% -64.5% -100.0% 100.0% 23.4% 12.9%
ROE 22.16
25.93
23.76
21.13
3.72
1.32
-50.18
1.97
2.21
2.55
growth rate 17.0% -8.4% -11.1% -82.4% -64.5% -100.0% 100.0% 12.2% 15.4%
ROIC 11.47
15.30
15.89
11.74
2.53
0.92
-28.89
1.12
1.42
1.62
growth rate 33.4% 3.9% -26.1% -78.5% -63.6% -100.0% 100.0% 26.8% 14.1%
Cur. Ratio 1.52
2.27
2.75
2.98
2.37
1.88
1.53
1.96
1.89
2.06
growth rate 49.3% 21.2% 8.4% -20.5% -20.7% -9.8% 28.1% -3.6% 9.0%
Quick Ratio 0.52
1.30
1.80
1.92
1.62
1.23
0.98
1.26
1.06
1.20
growth rate 150.0% 38.5% 6.7% -15.6% -24.1% -10.7% 28.6% -15.9% 13.2%
Leverage 2.85
2.09
2.17
2.30
1.60
1.85
2.33
1.88
1.94
1.95
growth rate -26.7% 3.8% 6.0% -30.4% 15.6% 12.2% -19.3% 3.2% 0.5%
Balance Sheet Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Dec '15 Oct '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 359.80
508.70
619.30
660.00
935.00
1,209.40
1,189.00
1,176.00
1,151.30
1,098.60
1,269.50
growth rate 41.4% 21.7% 6.6% 41.7% 29.4% -1.7% -1.1% -2.1% -4.6% 15.6%
Acct.Payable 584.17
612.60
382.00
364.00
709.30
555.80
471.70
450.20
474.90
520.20
growth rate 4.9% -37.6% -4.7% 94.9% -21.6% -15.1% -4.6% 5.5% 9.5%
Cur.Assets 1,402.70
1,377.29
1,795.90
2,257.00
2,551.00
3,229.00
2,791.60
2,805.30
2,819.60
2,902.20
2,756.90
growth rate -1.8% 30.4% 25.7% 13.0% 26.6% -13.6% 0.5% 0.5% 2.9% -5.0%
Total Assets 3,109.00
3,189.22
4,024.00
5,337.00
13,853.00
19,591.90
19,349.60
13,870.10
11,628.80
10,983.40
11,301.40
growth rate 2.6% 26.2% 32.6% 159.6% 41.4% -1.2% -28.3% -16.2% -5.6% 2.9%
Cash 109.80
310.10
602.50
780.00
800.00
785.60
417.80
622.30
678.70
551.10
354.30
growth rate 182.4% 94.3% 29.5% 2.6% -1.8% -46.8% 49.0% 9.1% -18.8% -35.7%
Inventory 453.00
505.58
547.50
704.00
632.00
935.70
898.70
795.00
806.90
878.00
967.30
growth rate 11.6% 8.3% 28.6% -10.2% 48.1% -4.0% -11.5% 1.5% 8.8% 10.2%
Cur.Liabilities 922.50
606.04
652.70
740.00
1,075.00
1,748.50
2,552.20
1,836.30
1,436.00
1,537.40
1,335.80
growth rate -34.3% 7.7% 13.4% 45.3% 62.7% 46.0% -28.1% -21.8% 7.1% -13.1%
Liabilities 2,016.90
1,658.23
2,171.40
3,004.00
5,159.00
8,892.40
9,242.80
7,912.50
5,458.20
5,315.30
5,497.30
growth rate -17.8% 31.0% 38.3% 71.7% 72.4% 3.9% -14.4% -31.0% -2.6% 3.4%
LT Debt 935.00
875.00
1,329.20
1,925.00
3,071.00
5,246.90
4,971.90
5,224.50
3,270.80
3,052.20
3,344.70
growth rate -6.4% 51.9% 44.8% 59.5% 70.9% -5.2% 5.1% -37.4% -6.7% 9.6%
Equity 1,092.10
1,529.04
1,851.00
2,331.40
8,692.90
10,699.30
10,107.40
5,958.10
6,170.50
5,668.00
5,803.80
growth rate 40.0% 21.1% 26.0% 272.9% 23.1% -5.5% -41.1% 3.6% -8.1% 2.4%
Common Shares 93.00
94.00
94.00
95.00
115.00
140.00
8,142.60
143.00
142.00
138.00
137.00
growth rate 1.1% 0.0% 1.1% 21.1% 21.7% 5,716.1% -98.2% -0.7% -2.8% -0.7%
Cash Flow Statement Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Dec '15 Oct '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 57.80
99.40
120.20
104.00
172.00
141.00
166.80
171.30
88.60
138.20
286.80
growth rate 72.0% 20.9% -13.5% 65.4% -18.0% 18.3% 2.7% -48.3% 56.0% 107.5%
Cash Dividends 22.30
25.30
29.00
33.00
46.10
64.80
72.20
83.20
91.10
104.90
112.40
growth rate 13.5% 14.6% 13.8% 39.7% 40.6% 11.4% 15.2% 9.5% 15.2% 7.2%
Cash From OA 332.40
374.00
513.40
554.00
694.00
855.20
764.30
654.90
698.90
593.00
387.80
growth rate 12.5% 37.3% 7.9% 25.3% 23.2% -10.6% -14.3% 6.7% -15.2% -34.6%
FCF per Share 2.78
2.94
3.38
5.14
3.91
6.56
6.12
4.28
3.76
2.61
growth rate 5.8% 15.0% 52.1% -23.9% 67.8% -3.4% -30.1% -12.2% -30.6%
Sale Purchase of Stock 6.00
3.40
10.70
9.80
1,043.50
9.00
8.30
-190.80
growth rate -43.3% 214.7% -8.4% 10,548.0% -99.1% -7.8% -100.0%
FCF 258.00
275.00
393.00
449.00
521.00
1,061.00
245.40
549.00
610.00
490.00
250.00
growth rate 6.6% 42.9% 14.3% 16.0% 103.7% -76.9% 123.7% 11.1% -19.7% -49.0%
Income Statement Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Dec '15 Oct '16 Dec '17 Dec '18 Dec '19
Sales 2,268.20
2,755.00
3,173.20
3,540.00
4,061.00
4,227.10
5,014.60
5,280.60
4,946.20
4,731.70
4,837.40
growth rate 21.5% 15.2% 11.6% 14.7% 4.1% 18.6% 5.3% -6.3% -4.3% 2.2%
Op.Income 335.90
340.60
393.00
442.00
205.00
729.80
735.30
661.90
692.50
483.90
444.20
growth rate 1.4% 15.4% 12.5% -53.6% 256.0% 0.8% -10.0% 4.6% -30.1% -8.2%
IBT 308.60
450.60
512.00
607.70
272.60
260.30
59.20
-4,848.30
280.10
290.60
171.00
growth rate 46.0% 13.6% 18.7% -55.1% -4.5% -77.3% -100.0% 100.0% 3.8% -41.2%
Net Income 223.80
340.60
393.00
442.00
205.00
136.10
-1.90
-4,012.80
119.60
131.00
146.10
growth rate 52.2% 15.4% 12.5% -53.6% -33.6% -100.0% 0.0% 100.0% 9.5% 11.5%
EPS 2.41
3.63
4.27
4.68
2.01
0.97
-28.01
0.84
0.95
1.07
growth rate 50.6% 17.6% 9.6% -57.1% -51.7% -100.0% 100.0% 13.1% 12.6%
Gross Profit 746.20
944.90
1,095.60
1,288.00
1,448.00
1,659.90
2,065.00
2,051.80
1,979.50
1,831.50
1,773.30
growth rate 26.6% 16.0% 17.6% 12.4% 14.6% 24.4% -0.6% -3.5% -7.5% -3.2%
R&D 102.50
89.30
105.80
115.20
152.50
187.80
186.20
184.00
167.70
218.60
187.40
growth rate -12.9% 18.5% 8.9% 32.4% 23.2% -0.9% -1.2% -8.9% 30.4% -14.3%

Quarterly Statements

Item Name Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Earnings BIT 90.10
148.20
145.70
121.10
108.50
growth rate 64.5% -1.7% -16.9% -10.4%
Balance Sheet Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Acct.Receivable 1,128.00
1,269.50
1,324.80
1,023.90
1,118.90
growth rate 12.5% 4.4% -22.7% 9.3%
Acct.Payable 524.90
520.20
555.80
489.10
536.40
growth rate -0.9% 6.8% -12.0% 9.7%
Cur.Assets 2,739.80
2,756.90
3,046.20
3,803.50
3,398.30
growth rate 0.6% 10.5% 24.9% -10.7%
Total Assets 11,310.80
11,301.40
11,400.70
12,128.30
11,576.00
growth rate -0.1% 0.9% 6.4% -4.6%
Cash 398.50
354.30
510.40
1,456.30
849.40
growth rate -11.1% 44.1% 185.3% -41.7%
Inventory 990.50
967.30
930.80
1,034.70
1,100.70
growth rate -2.3% -3.8% 11.2% 6.4%
Cur.Liabilities 1,324.70
1,335.80
1,635.00
1,859.70
1,336.30
growth rate 0.8% 22.4% 13.7% -28.1%
Liabilities 5,551.70
5,497.30
5,613.80
6,217.40
5,755.60
growth rate -1.0% 2.1% 10.8% -7.4%
LT Debt 3,340.50
3,344.70
3,163.60
3,517.00
3,523.80
growth rate 0.1% -5.4% 11.2% 0.2%
Equity 5,758.80
5,803.80
5,786.40
5,910.40
5,820.30
growth rate 0.8% -0.3% 2.1% -1.5%
Common Shares 7,378.80
7,359.90
7,339.60
7,318.20
7,299.70
growth rate -0.3% -0.3% -0.3% -0.3%
Cash Flow Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Capital Expenditures 86.80
110.30
66.50
26.40
45.50
growth rate 27.1% -39.7% -60.3% 72.4%
Cash Dividends 28.80
28.80
30.90
31.00
31.10
growth rate 0.0% 7.3% 0.3% 0.3%
Cash From OA 140.00
89.50
171.80
290.90
63.10
growth rate -36.1% 92.0% 69.3% -78.3%
Sale Purchase of Stock
growth rate
FCF 53.20
-20.80
105.30
264.50
17.60
growth rate -100.0% 100.0% 151.2% -93.4%
Income Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Sales 1,191.10
1,322.80
1,341.00
1,219.10
1,213.70
growth rate 11.1% 1.4% -9.1% -0.4%
Op.Income 90.10
148.20
145.70
121.10
108.50
growth rate 64.5% -1.7% -16.9% -10.4%
IBT 97.30
-34.20
114.70
71.80
-127.70
growth rate -100.0% 100.0% -37.4% -100.0%
Net Income 92.20
-19.00
106.40
60.60
-154.60
growth rate -100.0% 100.0% -43.1% -100.0%
EPS
growth rate
Gross Profit 412.80
480.80
483.20
434.70
428.10
growth rate 16.5% 0.5% -10.0% -1.5%
R&D 44.00
59.40
41.90
47.10
42.60
growth rate 35.0% -29.5% 12.4% -9.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

E (20.61)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 43.03 24.40 13.62
EPS / Growth -2.9% 1.67 5.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 3.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 3.2% 3.2%
Future PE 2.00 9.99 9.99
Future EPS 1.85 2.29 2.29
Value Price
MOS %
0.91
-97.8%
5.64
-86.2%
5.64
-86.2%
MOS Price 0.46 2.82 2.82
IRT 21.75 17.91 17.91

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.